Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

News: Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors
09/16Sernova Corp. Signs Collaboration Agreement to Advance Conformal Coated Immune Protected Therapeutic Cells for Diabetes with the University of Miami
CI
09/16Healixa, Inc. Forms Strategic Partnership in Guyana with Vitality SE
CI
09/16Physiomics's PARNTER Study Recruits First Patient
CI
09/16NeonMind Biosciences Inc. Appoints Roumen Milev as Clinical Lead of Providence Care Hospital Interventional Psychiatry to Its Specialty Clinics Advisory Board
CI
09/16MODERNA : Buy rating from Goldman Sachs
MD
09/16Co-Diagnostics, Inc. Announces its Joint Venture CoSara Diagnostics Pvt Ltd Receives Clearance from Central Drugs Standard Control Organization for Chikungunya and Dengue Tests
CI
09/16Asymchem and LaNova Medicines Enter into Partnership Agreement, Expanding Biological Capabilities
CI
09/16Neovasc Inc. Receives FDA Approval for the Investigational Device Exemption (“Ide”) Regarding the Cosira-II IDE Clinical Trial
CI
09/16Therapeutic Solutions International Identifies and Files Patent on Combination Effects Between its Nutraceutical QuadraMune™ and Ivermectin in Animal Models of COVID-19 Pathology
CI
09/16Rakovina Therapeutics Presents Preclinical Data on Novel kt-3000 Series Drug Candidates at JCA-AACR Precision Medicine International Conference
CI
09/16PharmaCyte Biotech, Inc Announces the First Test Results of the Biocompatibility Studies of Its CypCaps Clinical Trial Product Candidate
CI
09/16HCA Healthcare Names Mosier as Chief Nurse Executive
DJ
09/16Andlauer Healthcare Announces Dividend for the Third Quarter Ending September 30, 2021 , Payable on October 15, 2021
CI
09/16HCA Healthcare, Inc. Announces Executive Changes
CI
09/16ARCA Biopharma, Inc. Announces Enrollment of First International Patient in Phase 2B Clinical Trial Evaluating Rnapc2 as A Potential Treatment for Covid-19
CI
Discover
09/16Grove, Inc. Reports Unaudited Earnings Results for the Year Ended June 30, 2021
CI
09/16Grove, Inc. Provides Revenue Guidance for the Year Ending June 30, 2022
CI
09/16Soligenix, Inc. to Advance Synthetic Hypericin Development in Psoriasis
CI
09/16Aileron Therapeutics Presents New Clinical Data at European Society of Medical Oncology Virtual Congress 2021
CI
09/16Monopar Therapeutics Inc. Initiates Open-Label Phase 1b Clinical Trial Evaluating Camsirubicin in Patients with Advanced Soft Tissue Sarcoma
CI
09/16Adaptive Biotechnologies to Present New SARS-CoV-2 Data from its Immune Medicine Platform During IDWeek 2021
CI
09/16PRESS RELEASE : Paion ag announces initiation of pivotal study of remimazolam (byfavo(r)) in pediatric procedural sedation
DJ
09/16AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
CI
09/16Sundial Growers Inc. Launches Caviar Cones
CI
09/16Thermo Fisher Scientific Inc. Announces Automated Enzyme Analyzers Streamline Enzyme Assay Applications
CI
09/16Reflect Scientific Inc. Expands Cryometrix Distribution Channel
CI
09/16FluroTech Ltd. Provides Progress Update on Efforts to Bring Its Pandemic Response Platform to Market
CI
09/16Revance Therapeutics, Inc. Phase 3 Aspen-1 Clinical Trial Evaluating Efficacy, Duration of Effect and Safety of Daxibotulinumtoxina for Injection for Cervical Dystonia At International Parkinson and Movement Disorder Society Virtual Congress 2021
CI
09/16Ayala Pharmaceuticals, Inc. Announces Pre-Clinical Proof of Concept Data for Enhanced Activity of AL101 in Combination with Approved Cancer Therapies in ACC
CI
09/16NGM Biopharmaceuticals, Inc. Presents Preliminary Findings from Ongoing Phase 1A/1B Dose Escalation Study of NGM120 in Patients with Advanced Solid Tumors at the ESMO Virtual Congress 2021
CI
09/16Harvest Health & Recreation Inc. Opens Thirteenth Florida Dispensary in Kissimmee
CI
09/16Daiichi Sankyo Company, Limited and AstraZeneca announce first patient dose in DESTINY-Gastric06
CI
09/16IOL Chemicals and Pharmaceuticals Limited Recommends Final Dividend for the Financial Year 2020-21
CI
09/16LexaGene Enters into Cooperative Research and Development Agreement with the United States army’s Combat Capabilities Development Command
CI
09/16ScreenPro Security Inc. Provides COVID-19 Testing At the Toronto International Film Festival
CI
09/16Neovasc Gets FDA Approval for Reducer Clinical Trial
DJ
09/16Biobiogen Inc. Announces Positive Topline Results from Phase 2 Convey Study in Small Fiber Neuropathy
CI
09/16Intellia Therapeutics, Inc. announces U.S. Food and Drug Administration accept the investigational new drug application for NTLA-5001
CI
09/16Zai Lab Limited Expands U.S. Operations to Join the Cambridge Biotechnology Community
CI
09/16PHILIPS NV : JP Morgan from Sell to Neutral
MD
09/16Flora Growth Signs Letter of Intent Robust Farms Inc. to Supply Its Premium Cannabidiol Derivative Products from Its Kasa Wholefoods Division
CI
09/16Phio Pharmaceuticals Presents Data at ESMO 2021 Demonstrating Persistent Anti-Tumor Immunity with INTASYL Dual-Targeting PD-1 and BRD4
CI
09/16RepliCel Life Sciences Inc. and University of Victoria Collaboration Leads to Bioengineering Innovations, Funding, and Patents
CI
09/16Sativa Wellness Group Announces Launch of Its` Best Price, Best Quality Cbd Oil with Guarantee
CI
09/16Zymeworks Inc. Announces New Clinical Data for Zanidatamab, A Her2-Targeted Bispecific Antibody, Demonstrate Promising Response Rates and Durability in First-Line Her2- Positive Gea
CI
09/16Castle Biosciences, Inc. Announces New York Approval of Decisiondx Diffdx-Melanoma
CI
09/16Axsome Therapeutics Initiates SYMPHONY Phase 3 Trial of AXS-12 in Narcolepsy
CI
09/16Harborside Inc. Enters into A Strategic Research Agreement with Utah State University
CI
09/16Instil Bio Presents Subset Analysis of Patients with Checkpoint-Refractory Advanced Melanoma from Compassionate Use Study at 2021 ESMO Congress
CI
09/16Sutro Biopharma, Inc. Announces Management Changes
CI
09/16Autolus Therapeutics Provides an Update on its Manufacturing Facility in Stevenage, UK
CI
09/16Gilead Sciences, Inc Announces New Data Demonstrate Trodelvy Survival Benefit in Metastatic Triple-Negative Breast Cancer Patients Regardless of Initial HR/HER2 Status
CI
09/16Alx Oncology Holdings Inc. Announces Initiation of Investigator-Sponsored Trial of Evorpacept in Patients with Indolent and Aggressive Non-Hodgkin Lymphoma
CI
09/16Bristol Myers Squibb Announces Five-Year Data from Checkmate -214 Show Opdivo Plus Yervoy Demonstrates Longest Median Overall Survival Currently Reports in Phase 3 Trial of Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
CI
09/16Aptinyx Inc. Enters into $50 Million Loan Facility and Security Agreement with K2 HealthVentures
CI
09/16AbbVie Submits Regulatory Applications for Treatment of Ulcerative Colitis
DJ
09/16Gilead Says Trodelvy Improved Quality of Life in Breast Cancer in Study
DJ
09/16PRESS RELEASE : Gaia grow provides update on canna stream solutions' equipment and product development
DJ
09/16Biogen Drug Candidate for Small Fiber Neuropathy Meets Primary Endpoint for 200 Milligram Dose
DJ
09/16INTELLIA : FDA Accepts NTLA-5001 IND in Acute Myeloid Leukemia
DJ
09/16Philip Morris Confirms Majority of Vectura Shareholders Agree to Takeover
CI
09/16Lumosa Receives Phase 2 Clinical Trialapproval by FDA for LT3001 in Combination with Mechanical thrombectomy on Patients with Acute Ischemic Stroke
CI
09/16CSPC Pharmaceutical Group Limited Declares Interim Dividend for the Year 2021, Payable on October 8, 2021
CI
09/16HARDMAN & CO RESEARCH : Diurnal Group (DNL): All set for three pivotal trials
DJ
09/16Shanghai Henlius Biotech, Inc. Announces New Drug Application of Serplulimab Injection(Recombinant Humanised Anti-Pd-1 Monoclonal Antibodyinjection) in Combination with Chemotherapy for Thefirst-Line Treatment
CI
Discover
09/16Lansen Pharmaceutical Holdings Limited Declares Special Dividend, Payable on September 28, 2021
CI
09/16Camurus AB Announces FDA Grants Orphan Drug Designation in the US for CAM2029 for the Treatment of Polycystic Liver Disease
CI
09/16Aevis Victoria Sa Reports Earnings Results for the Half Year Ended June 30, 2021
CI
09/16Novacyt Says Covid-19 Contract Dispute with UK Health Department Continues
DJ
09/16Amgen Inc. Announces the First Combination Study Results from the Phase 1B/2 Codebreak 101 Study
CI
Prev.1  2  3   4  5  6  7  8  9  10Next